BCBC — BC Bud Income Statement
0.000.00%
Last trade - 00:00
- CA$1.93m
- CA$2.09m
- CA$0.99m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2022 February 28th | 2023 February 28th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0.99 |
Cost of Revenue | |||||
Gross Profit | — | — | — | 0 | -0.143 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.505 | 0.298 | 0.144 | 2.85 | 2.08 |
Operating Profit | -0.505 | -0.298 | -0.144 | -2.85 | -1.09 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.508 | -0.292 | -0.143 | -2.86 | -1.09 |
Net Income After Taxes | -0.508 | -0.292 | -0.143 | -2.86 | -1.09 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.508 | -0.292 | -0.143 | -2.86 | -1.09 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.508 | -0.292 | -0.143 | -2.86 | -1.09 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.117 | -0.065 | -0.017 | -0.028 | -0.024 |